The extracellular release of HMGB1 during apoptotic cell death.
about
Oncolytic viruses as therapeutic cancer vaccinesInduction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 proteinCirculating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesWhole Tumor Antigen Vaccines: Where Are We?The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseasesOxidative stress-mediated HMGB1 biologyPAMPs and DAMPs: signal 0s that spur autophagy and immunityCell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexesThe translocation of nuclear molecules during inflammation and cell deathEmerging roles for HMGB1 protein in immunity, inflammation, and cancerMénage à Trois in stress: DAMPs, redox and autophagyHMGB1 loves companyTargeting HMGB1 in inflammationGlucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expressionOxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusionA hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammationA Multiscale Agent-Based in silico Model of Liver Fibrosis ProgressionBax shuttling after neonatal hypoxia-ischemia: hyperoxia effects.Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancerImmunogenic and tolerogenic cell death.Emerging role of HMGB1 in lung diseases: friend or foe.The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis.Stepwise release of biologically active HMGB1 during HSV-2 infection.Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation.High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.Effects of single or combined treatments with radiation and chemotherapy on survival and danger signals expression in glioblastoma cell lines.The role of high mobility group box 1 in innate immunity.Dose-dependent effect of mitomycin C on human vocal fold fibroblastsNucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.Milk fat globule EGF factor 8 attenuates sepsis-induced apoptosis and organ injury in alcohol-intoxicated rats.HMGB1 release and redox regulates autophagy and apoptosis in cancer cells.High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity.Milk fat globule-EGF factor VIII in sepsis and ischemia-reperfusion injuryLentivirus delivery of IL-10 to promote and sustain macrophage polarization towards an anti-inflammatory phenotype.Ultraviolet light exposure stimulates HMGB1 release by keratinocytesHigh-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.
P2860
Q21245758-7612BA5B-370E-417C-98CF-D9B4830FB49CQ24314282-513BFE4D-CD79-4AFD-A266-617AD2D3E9AFQ26768480-6FE01844-FF6C-4478-ADB6-67201542D6D1Q26781215-E777EF88-D914-42A0-A671-9B57BE83D050Q26783866-89EAC259-F6BF-424C-945F-3A6EAE9481F7Q26829321-45484B8F-8562-4806-982E-8C7DA3D481DBQ27000955-8670FD4A-9C22-4387-8B06-2C85F221BA63Q27004190-622E02EC-68C1-4B55-87A5-92BC8E3C828BQ27008742-A59AEA88-FF35-4892-9FC2-A999F0BBF6C4Q27010599-733DBBCF-B58E-4167-9735-8BFC50471C32Q27015835-E0A6B7DC-B280-4A65-BD06-7E607D7B0ECAQ27023542-ACFF21DB-5CE6-4831-B38F-160D24DB9AE4Q28243671-F2DD008C-1539-4743-A5BC-3E25F98CFDA2Q28266138-09EC528D-E149-48BD-8AF1-1EA269DDD5A6Q28570190-F70384AC-9F74-4C6D-A6CD-50A323D3C54AQ28579337-08E00523-62C2-4A30-8AF7-D036AEFF61F6Q28742970-B21F5DE5-BC14-4479-8AD1-149C3840D18BQ30432589-C85B05D9-9041-45B0-BF46-98F0C571E653Q30492381-DD4F1F85-827F-4D4C-A654-A4DB827AEEA7Q33602876-DCE448DC-90AF-4338-B56C-9D379EEE70A3Q33639097-8F82E8FD-873C-4941-9B12-549496F0EDEDQ33684145-34892DEB-2558-488B-A5E6-D9C00FC29194Q33732343-07D415FC-40DC-4DD8-B406-95929378FF49Q33809521-149416F6-79D3-46BA-B49F-DF6319FEF97DQ33814903-46220687-C725-4076-B9F4-499F1FE24731Q33829272-4A82D8B6-3E10-4519-99FF-DF77E75EAB06Q33836853-400188F5-4DEE-46E9-904B-82D56BA26868Q33908539-C561419D-58CC-4B9C-965D-A350919C622DQ33941549-591C1B13-0692-42FB-84F8-8BAD7F7098AAQ33960487-DC62B8C4-52B8-483A-A5F0-6E737B85DB42Q34017633-D4D2E1E4-5612-4C99-B092-EB68922BA803Q34017957-8C4122E8-0903-4C41-A875-4237512CA7E8Q34088576-8D56F70E-F99D-4563-9576-854767EFD2A7Q34154797-2B924705-FCA8-47F6-A19E-0105D2E598D3Q34203942-B28CD124-7D7D-4018-80E5-BE1583300349Q34400931-74D91EB7-AF42-42F1-A81F-EC805CA2DF27Q34500747-B09FA2E9-3C11-4A8C-A627-63A07153F074Q34512267-30830D4B-78F0-4F8B-940D-1D267C747EB6Q34655362-889CEB6C-DC3F-4CBC-BC31-E4280DEB69D1Q34987778-7B34C629-2506-4947-AF6C-310368F04539
P2860
The extracellular release of HMGB1 during apoptotic cell death.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The extracellular release of HMGB1 during apoptotic cell death.
@en
type
label
The extracellular release of HMGB1 during apoptotic cell death.
@en
prefLabel
The extracellular release of HMGB1 during apoptotic cell death.
@en
P2093
P2860
P1476
The extracellular release of HMGB1 during apoptotic cell death.
@en
P2093
Charles F Reich
Charles W Bell
David S Pisetsky
Weiwen Jiang
P2860
P304
P356
10.1152/AJPCELL.00616.2005
P577
2006-07-19T00:00:00Z